Streetinsider

Published September 16, 2026

Optimi Health plans Phase 3 MDMA -assisted therapy trial for PTSD - StreetInsider

Read the full story at Streetinsider

(NASDAQ: OPTH) (CSE: OPTI) announced plans to initiate a Health Canada-authorized Phase 3 clinical trial evaluating MDMA -assisted ... (Premium.